TY - JOUR
T1 - Preoperative botulinum A toxin as an adjunct for abdominal wall reconstruction
T2 - a single-center early experience at an Academic Center in New York
AU - Mandujano, Cosman Camilo
AU - Lima, Diego Laurentino
AU - Alcabes, Analena
AU - Friedmann, Patricia
AU - Pereira, Xavier
AU - Malcher, Flavio
N1 - Publisher Copyright:
© 2022, Colegio Brasileiro de Cirurgioes. All rights reserved.
PY - 2022
Y1 - 2022
N2 - Introduction: the botulinum toxin A (BTA) has been used to achieve a chemical component separation, and it has been used with favorable outcomes for the repair of complex ventral hernia (CVH) with and without loss of domain (LD). The aim of this study is to describe our early experience with the chemical component separation in the United Sates. Methods: a retrospective observational study of all patients who underwent ventral hernia repair for CVH with or without LD between July 2018 and June 2020. Preoperative BTA was injected in all patients via sonographic guidance bilaterally, between the lateral muscles to achieve chemical denervation before the operation. Patient demographics, anatomical location of the hernia, perioperative data and postoperative data are described. Results: 36 patients underwent this technique before their hernia repair between July 2018 to June 2020. Median age was 62 years (range 30-87). Median preoperative defect size was 12cm (range 6-25) and median intraoperative defect size was 13cm (range 5-27). Median preoperative hernia sac volume (HSV) was 1338cc (128-14040), median preoperative abdominal cavity volume (ACV) was 8784cc (5197-18289) and median volume ration (HSV/ACV) was 14%. The median OR time for BTA administration was 45 minutes (range 28-495). Seroma was the most common postoperative complication in 8 of the patients (22%). Median follow up was 43 days (range 0-580). Conclusion: preoperative chemical component separation with BTA is a safe and effective adjunct to hernia repair in CVH repairs where a challenging midline fascial approximation is anticipated.
AB - Introduction: the botulinum toxin A (BTA) has been used to achieve a chemical component separation, and it has been used with favorable outcomes for the repair of complex ventral hernia (CVH) with and without loss of domain (LD). The aim of this study is to describe our early experience with the chemical component separation in the United Sates. Methods: a retrospective observational study of all patients who underwent ventral hernia repair for CVH with or without LD between July 2018 and June 2020. Preoperative BTA was injected in all patients via sonographic guidance bilaterally, between the lateral muscles to achieve chemical denervation before the operation. Patient demographics, anatomical location of the hernia, perioperative data and postoperative data are described. Results: 36 patients underwent this technique before their hernia repair between July 2018 to June 2020. Median age was 62 years (range 30-87). Median preoperative defect size was 12cm (range 6-25) and median intraoperative defect size was 13cm (range 5-27). Median preoperative hernia sac volume (HSV) was 1338cc (128-14040), median preoperative abdominal cavity volume (ACV) was 8784cc (5197-18289) and median volume ration (HSV/ACV) was 14%. The median OR time for BTA administration was 45 minutes (range 28-495). Seroma was the most common postoperative complication in 8 of the patients (22%). Median follow up was 43 days (range 0-580). Conclusion: preoperative chemical component separation with BTA is a safe and effective adjunct to hernia repair in CVH repairs where a challenging midline fascial approximation is anticipated.
KW - Botulinum A toxin
KW - Hernia
KW - Laparoscopic surgery
KW - Robotic surgery
UR - http://www.scopus.com/inward/record.url?scp=85125688215&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125688215&partnerID=8YFLogxK
U2 - 10.1590/0100-6991e-20213152
DO - 10.1590/0100-6991e-20213152
M3 - Article
C2 - 35239848
AN - SCOPUS:85125688215
SN - 0100-6991
VL - 49
JO - Revista do Colegio Brasileiro de Cirurgioes
JF - Revista do Colegio Brasileiro de Cirurgioes
M1 - e20213152
ER -